Walgreens reported a 3.3 percent gain in sales and adjusted earnings per share of $1.16, higher than the $1.10 consensus among analysts. The company benefited from its healthcare business, which posted $1.6 billion in revenues, up from $500 million a year earlier. Pharmacy sales declined 0.3 percent.